Campbell Bunce

Overview

Chief Scientific Officer of Abzena, 25 years translating complex science into manufacturable therapeutics with a focus on advanced modalities. Campbell Bunce serves as Chief Scientific Officer of Abzena and has spent approximately 25 years focused on translating complex science into manufacturable and scalable therapeutics, with recent emphasis on advanced modalities. Bunce advocates a developability approach for novel modalities, treating manufacturability as a priority design criterion that must be evaluated at the earliest stage before scale-up is attempted. (Segment 1 (00:00-05:00))